Bactericidal studies of penicillin-gentamicin combinations against group B streptococci.

Abstract
The bactericidal activity of penicillin-aminoglycoside combinations was studied in 16 strains of Group B streptococci. Minimal inhibitory concentrations (MIC) against kanamycin or gentamicin were greater than 50 .mu.g/ml, whereas ampicillin or penicillin inhibitory concentrations were uniformly less than 0.1 .mu.g/ml. Although all strains had bactericidal concentrations (MBC) less than 0.1 .mu.g penicillin/ml, penicillin at a concentration equal to each strains respective MBC reduced inoculum colony forming units (CFU) 2 logs in only 6 of 16 strains in bactericidal kinetic studies. The addition of gentamicin in concentrations of 5.0 or 10.0 .mu.g/ml to penicillin markedly enhanced bactercidal activity in all strains tested. The addition of lower concentrations of gentamicin (1.0 .mu.g/ml) had minimal advantage over penicillin alone. No distinct advantage was noted for combinations including either ampicillin or kanamycin. The theoretical advantage of penicillin-aminoglycoside combinations in experimental conditions, suggests that the use of antibiotic combinations in clinical infections due to Group B streptococci, may result in a more rapid eradication of these organisms.